Sep 25, 2026 06:48AM
Sep 24, 2026 06:01AM
Aug 11, 2026 05:14PM
Jun 22, 2026 08:02AM
Jun 4, 2026 06:41AM
Jun 3, 2026 08:03AM
May 12, 2026 05:30PM Kyverna Therapeutics, Inc. (KYTX) Tops Q1 EPS by 38c
May 12, 2026 04:02PM
Apr 23, 2026 07:10AM
Apr 22, 2026 09:38AM
Apr 22, 2026 07:03AM
Mar 26, 2026 04:24PM
Jan 12, 2026 08:09AM
Dec 15, 2025 02:34PM Kyverna Therapeutics Inc (KYTX) PT Raised to $33 at Morgan Stanley
Dec 15, 2025 06:30AM
Nov 13, 2025 05:05PM
Nov 3, 2025 08:03AM
Oct 27, 2025 06:49AM
Oct 8, 2025 06:01AM
Sep 25, 2025 04:10PM
Sep 25, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Kyverna Therapeutics Inc (KYTX)
Aug 29, 2025 06:53AM
Aug 20, 2025 05:06AM
Aug 12, 2025 06:06PM
Jun 30, 2025 09:03AM
May 14, 2025 05:21PM
Apr 3, 2025 06:46AM
Mar 27, 2025 04:53PM Kyverna Therapeutics (KYTX) Files $250M Mixed Shelf
Mar 14, 2025 12:52PM
Feb 6, 2025 07:24PM
Feb 4, 2025 10:28AM
Feb 3, 2025 05:44PM
Feb 2, 2025 09:00AM
Jan 29, 2025 10:00AM
Jan 28, 2025 06:33PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 27, 2025 01:44PM
Jan 26, 2025 02:31PM
Jan 26, 2025 08:13AM
Jan 25, 2025 12:18PM
Jan 23, 2025 11:05PM
Jan 23, 2025 03:16PM
Jan 22, 2025 08:54PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
Jan 21, 2025 04:07PM
Jan 19, 2025 08:04AM
Jan 18, 2025 04:15PM
Jan 16, 2025 07:03PM
Jan 15, 2025 06:58PM
Jan 14, 2025 06:58PM
Jan 13, 2025 07:05PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Jan 12, 2025 03:23PM

466,310 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All